申请人:Pfizer Inc.
公开号:US04473704A1
公开(公告)日:1984-09-25
1,2,3,4,4a,4b,5,6,7,8,8a,12b-Dodecahydro-7-(oxo, hydroxy or amino)-9-hydroxy-11-(alkyl, alkoxy or alkoxyalkyl)triphenylenes, 2,3,3a,3b,4,5,6,7,7a,11b-decahydro-6-(oxo, hydroxy or amino)-8-hydroxy-10-(alkyl, alkoxy or alkoxyalkyl)-1H-cyclopenta[1]phenanthrenes, 2,3,4,4a,4b,5,6,7,8,8a-decahydro-7-(oxo, hydroxy or amino)-9-hydroxy-11-(alkyl, alkoxy, alkoxyalkyl, aralkyl, aralkoxy, aryloxyalkyl or aralkoxyalkyl)-1H-pyrido[1,2-f]phenanthridines, and 1,2,3,3a,3b,4,5,6,7,7a-decahydro-6-(oxo, hydroxy or amino)-8-hydroxy-10-(alkyl, alkoxy or alkoxyalkyl)pyrrolo[1,2-f]phenanthridines and derivatives are valuable as central nervous system active agents or as intermediates to compounds having such activity.
1,2,3,4,4a,4b,5,6,7,8,8a,12b-十二氢-7-(氧代、羟基或氨基)-9-羟基-11-(烷基、烷氧基或烷氧基烷基)三苯基烯,2,3,3a,3b,4,5,6,7,7a,11b-十氢-6-(氧代、羟基或氨基)-8-羟基-10-(烷基、烷氧基或烷氧基烷基)-1H-环戊[1]菲,2,3,4,4a,4b,5,6,7,8,8a-十氢-7-(氧代、羟基或氨基)-9-羟基-11-(烷基、烷氧基、烷氧基烷基、芳烷基、芳烷氧基、芳氧基烷基或芳烷氧基烷基)-1H-吡啶并[1,2-f]菲啶,以及1,2,3,3a,3b,4,5,6,7,7a-十氢-6-(氧代、羟基或氨基)-8-羟基-10-(烷基、烷氧基或烷氧基烷基)吡咯并[1,2-f]菲啶及其衍生物,作为中枢神经系统活性剂或作为具有此类活性的化合物的中间体具有重要价值。